维普中文期刊产品整合服务
25篇 您的检索式:作者名="YANNIS L"
    题名 作者 年代 出处 被引量
1Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye显示文摘Nagelhout TJ Gamache DA Roberts L Brady MT Yanni JM 2005J Ocul Pharmacol Ther2005,21,2:1
2Internal Capabilities and External Knowledge Sources: Complements or Substitutes for Innovative Performance? 显示文摘YANNIS C IOANNA L AGGELOS T 2004Technovation2004,24,1:1
3Generation of 60-GHz MB-OFDM Signal-Over-Fiber by Up-Conversion Using Cascaded External Modulators 显示文摘GIANG H N BEATRICE C YANNIS L G 2009Journal of Lightwave Technology2009,27,912:1
4Internal Capabilities and Exter- nal Knowledge Sources: Complements or Substitutes for Innova- tive Peffonnance显示文摘Yannis C Ioanna L Aggeios T 2004Technovation2004,,24:1
5Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization 显示文摘McNatt LG Weimer L Yanni J 1999J Ocul Pharmacol Ther1999,15,5:1
6Glycogen synthase kinase - 313 inhibition induces nuclear factor - KB - mediated apoptosis in pediat- ric acute lymphocyte leukemia ceils显示文摘Yanni H Xiaoyan G Ruiyan L 2010J Exp Clin Cancer Res2010,154,:1
7Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization显示文摘McNatt LG Weimer L Yanni J 1999Ocul Pharmacol Ther1999,15,5:1
8Slip-flow Heat Transfer in Circular Tubes显示文摘Francisco E L Christos H Yannis D 2000International Journal of Heat and Mass Transfer2000,43,15:1
9Novel liposome-based multicomponent systems for the protection of photolabile agents显示文摘 Pramukh J Gregory G 1995International Journal of Pharmaceutics1995,117,1:1
10Employment of 4-(1-imidazolyl) phenol as a Luminol Signal Enhancer in a Competitive-type Cheminuluminescence Immunoassay and Its Comparison with the Conventional Antigen-horseradish Peroxidase Conjugate-based Assay显示文摘Yannis D Yannis L L 2004Analytica Chemica Acta2004,509,1:1
11Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization 显示文摘McNATT LG Weimer L Yanni J 1999J Ocular pharmacology & therapeutics1999,15,5:1
12Different distrib- ution patterns of cerebral microbleeds in acute ischemic stroke pationts with and without hypertension 显示文摘Jian S Yannie Y S Wynnie W M L 2009Eur Neurology2009,62,:1
13Towards an ART-based mathematical editor, that uses on-line handwritten symbol recognition显示文摘Yannis A Dimitriadis Coronado J L 1995Pattern Recognition1995,28,6:1
14Ontology-Enabled pervasive computing applications 显示文摘RYUSUKE M YANNIS L 2003IEEE Intelligent Systems2003,910,:1
15Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-na?ve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety显示文摘AIM To evaluate sustained viral response(SVR) of 8-wk ledipasvir/sofosbuvir therapy among non-cirrhotic, genotype-1 hepatitis C virus(HCV) patients with RNA < 6 million IU/m L.METHODS We performed a retrospective cohort study to examine SVR rates, predictors of treatment failure and safety analysis of 8-wk ledipasvir/sofosbuvir(LDV/SOF) therapy among non-cirrhotic, genotype 1 HCV patients with viral load < 6 million IU/m L. Primary outcome was an achievement of SVR at 12 wk after treatment. Secondary outcomes were identifying predictors of treatment failure and adverse events during treatment.RESULTS Total 736 patients: 55% males, 51% Caucasians and 65% were genotype 1a. Non-cirrhotic state of 53% was determined by clinical judgment(imaging, AST, platelet count) and 47% had documented liver fibrosis testing(biopsy, vibration-controlled transient elastography, serum biomarkers). Overall SVR12 was 96%. No difference in SVR12 was seen between patients whose non-cirrhotic state was determined by clinical judgment and patients who had fibrosis testing. Age groups, gender, ethnicity and genotype 1 subtype did not predict SVR. Non-cirrhotic state determined by clinical judgment based on simple, non-invasive tests were not associated with lower SVR [OR = 1.02, 95%CI: 0.48-2.17, P = 0.962]. The AUROC for hepatitis C RNA viral load was 0.734(P < 0.001, 95%CI: 0.66-0.82). HCV RNA 2.2 million IU/m L was identified as the cutoff value with sensitivity 73% and specificity 64%. HCV RNA < 2.2 million IU/m L was associated with significantly higher SVR 98% with OR = 0.22(95%CI: 0.1-0.49, P < 0.001) compared to SVR 92% in HCV RNA ≥ 2.2 million IU/m L. No death or morbidities were reported.CONCLUSION Our outcomes validate safety and effectiveness of 8-wk LDV/SOF therapy in non-cirrhotic, untreated HCV genotype 1 patients with HCV RNA < 6 million IU/m L.Nyan L Latt Beshoy T Yanny Derenik Gharibian Rita Gevorkyan Amandeep K Sahota 2017World Journal of Gastroenterology2017,23,26:1
16Evaluation of the methods for the determination of the stability constant of cyclodextrin chlorambucil inclusion complexes 显示文摘Loukas Yannis L 1997J Pharm Biomed Anal1997,16,2:1
17Evaluating Strategies for Sustainable Development:Fuzzy Logic Reasoning and Sensitivity Analysis显示文摘Vassilis L A Yannis S K Phillis A 0,,48:1
18A Plackett-Burman screening design directs the efficient formulation of multicomponent DRV liposomes显示文摘Yannis L Loukas 2001Journal of Pharmaceutical and Biomedical Analysis2001,26,:1
19Urban water management in Greece present conditions and perspective of sustainability显示文摘Yannis M L 2003IWRA International2003,28,1:1
20Development of transgenic tobacco plants overexpressing maize glutathione S-transferase I for chloroacetanilide herbicides phytoremediation显示文摘Karavangeli M Nikolaos E L Yannis D C 2005Biomolecular Engineering2005,22,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费